The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

A new study published in the peer-reviewed journal Human Gene Therapy involved the generation of a human monoclonal antibody ...

Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Gene Therapy Market offers comprehensive insights into the market landscape, customer intelligence, ...

Treatments for rare diseases are hard to create and expensive to deliver, but there is new hope for editing the software of ...

An update from JCR Pharmaceuticals Co., Ltd. ( (JP:4552) ) is now available.

Robust pipelines emphasize expanded clinical trials, global R&D partnerships, and streamlined rare disease approvals.

The gene therapy for an undisclosed central nervous system disease is based on JCR's delivery technology and Modalis' epigenome editing platform.

In a recent study published in the journal Nature Biotechnology, researchers explored the potential of artificial intelligence (AI) techniques to improve gene therapy delivery systems specifically ...

7, 2024 — Bioengineers have developed a noninvasive tool to measure gene expression and gene therapy delivery in specific ... Improved Prime Editing System Makes Gene-Sized Edits in Human ...

The latest update is out from Modalis Therapeutics Corporation ( (JP:4883) ).

JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease: Hyogo, Japan Tuesday, January 7, 20 ...